drugset

drugset / Trial / NCT00108511

Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides

NCT00108511 ↗

Phase 1 Completed US Department of Veterans Affairs

RandomizedFactorialDouble-blindTreatment

Summary

The purpose of this study is to examine the role of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD) in triglyceride metabolism.

Timeline

Start: 2004-10
Primary completion: —
Completion: 2007-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Gemfibrozil	Small molecule	—	—

Indications